Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00450671 · ClinicalTrials.gov registry record · Phase 3

Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug

A Phase 3 study of Anal Fistula, sponsored by University of Southern California.

Completed
Registry status
Phase 3
Development phase
300
Enrollment target
4
Study locations

NCT00450671: Completed Phase 3 study of Anal Fistula, sponsored by University of Southern California.

NCT00450671 is a Phase 3 study of Anal Fistula that has completed, run by University of Southern California. The registered enrollment target is 300 participants, above the 242-participant average among 5 other Anal Fistula trials with a reported enrollment target (24% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00450671, a Phase 3 study of Anal Fistula, has completed, sponsored by University of Southern California.

COMPLETED
Registry status
Phase 3
Development phase
300 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to determine if the collagen plug method heals perirectal fistulae as well as the conventional seton method.

Conditions Studied

Interventions

  • PROCEDURE Collagen Plug Placement
  • PROCEDURE Seton placement

Study Locations (4)

California

  • H.Claude Hudson Comprehensive Health Center - Los Angeles
  • Los Angeles County-USC Medical Center - Los Angeles
  • USC Norris Cancer Center - Los Angeles
  • USC/University Hospital - Los Angeles

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2007-02
Est. Completion 2013-05-09
Phase Phase 3
University of Southern California

617 total trials

What the finished NCT00450671 record still lists

NCT00450671 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 242-participant average among 5 other Anal Fistula trials with a reported enrollment target (24% higher).

The record links to 1 condition, with Anal Fistula appearing as the primary indexed condition, and to 2 interventions - of which Collagen Plug Placement is the first listed.

NCT00450671 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00450671 about?

NCT00450671 is a clinical study titled "Treatment of Perirectal Fistula With Cutting Seton vs. Collagen Plug". The purpose of this study is to determine if the collagen plug method heals perirectal fistulae as well as the conventional seton method.

What is the current status of trial NCT00450671?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 300 participants. The study started on 2007-02. Estimated completion is 2013-05-09.

What conditions does trial NCT00450671 study?

This clinical trial studies the following conditions: Anal Fistula.

What interventions are being tested in trial NCT00450671?

The interventions under investigation include: Collagen Plug Placement (PROCEDURE), Seton placement (PROCEDURE).

Who is sponsoring clinical trial NCT00450671?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00450671 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anal Fistula

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00450671, the US trial registry maintained by the National Library of Medicine. NCT00450671 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.